Axelle Pintiaux
ORCID: 0000-0002-2562-2071
· 6 papers in corpus
guideline
2025
INTRODUCTION: Exogenous and endogenous sex hormones, especially Progesterone agonists, may be causally linked to meningioma progression. Cessation of treatment leads to stabilization or regression of Progestin-induced meningioma. In many ca…
case-report
2024
Selective progesterone receptor modulators (SPRMs) are synthetic steroid compounds that interact with the progesterone receptor, inducing various agonist, antagonist or mixed responses. First identified with mifepristone, they are now repre…
review
2015
OBJECTIVE: Since its introduction 50 years ago, the contraceptive pill has continuously evolved to decrease the risk of venous thromboembolism (VTE) associated with its use. An increased risk of VTE still remains, however. Other concerns, s…
review
2012
Selective progesterone receptor modulators (SPRMs) have been developed since the late 70s when mifepristone was first described. They act through nuclear progesterone receptors and can have agonist or mixed agonist antagonist actions depend…
2010
En contraception orale estroprogestative, la reduction drastique, aussi bien des doses d'ethinyl-estradiol que des progestatifs androgeniques derives de la 19 NOR testosterone, a permis de diminuer moderement l'impact metabolique et vascula…
review
2009
Selective progesterone receptor modulators (SPRM) represent a new class of synthetic steroids, which can interact with the progesterone receptor (PR) and can exert agonist, antagonist or mixed effects on various progesterone target tissues …